Prenatal exposure to loratadine in children with hypospadias: A nested case-control study within the Danish National Birth Cohort

American Journal of Therapeutics

Volumn 13, Issue 4, 2006, Pages 320-324

  Pedersen, Lars ^a   Nørgaard, Mette ^a   Skriver, Mette Vinther ^a   Olsen, Jørn ^b   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF AARHUS   (Denmark)

Author keywords

Case control studies; Drug safety; Hypospadias; Loratadine; Pregnancy

Indexed keywords

ANTIHISTAMINIC AGENT; LORATADINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONCEPTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG SAFETY; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOSPADIAS; INTERVIEW; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERIUM; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICAL ANALYSIS; TELEPHONE;

ADULT; ANTI-ALLERGIC AGENTS; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; DENMARK; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; HYPOSPADIAS; LORATADINE; MALE; PREGNANCY; PREGNANCY OUTCOME;

EID: 33749364363     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200607000-00008     Document Type: Article

References (29)

1. Carmichael SL, Shaw GM, Nelson V, et al. Hypospadias in California. Trends and descriptive epidemiology. Epidemiology. 2003;14:701-706.
2. Matlai F, Beral V. Trends in congenital malformations of external genitalis. Lancet. 1985;1:108.
3. Bjerkedal T, Bakketeig LS. Surveillance of congenital malformations and other conditions of the newborn. Int J Epidemiol. 1975;4:31-36.
4. Kallen B, Winberg J. An epidemiologic study of hypospadias in Sweden. Acta Paediatr Scand Suppl. 1982;293:1-52.
5. Silver RI, Rodriguez R, Chang TS, et al. In vitro fertilization is associated with an increased risk of hypospadias. J Urol. 1999;161:1954-1957.
6. Czeizel A. Increasing trends in congenital malformations of male external genitalia. Lancet. 1985;1:462-463.
7. Paulozzi LJ, Erickson D, Jackson RJ. Hypospadias in trends in two US surveillance systems. Pediatrics. 1997;100:831-834.
8. Gallentine ML, Morey AF, Thompson I. Hypospadias: a contemporary epidemiologic assessment. Urology. 2001;57:788-790.
9. Åberg A, Westbom L, Källén B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev. 2001;61:85-95.
10. Fredell L, Kockum I, Hansson E, et al. Heredity of hypospadias and the significance of low birth weight. J Urol. 2002;167:1423-1427.
11. Hussain N, Chaghtai A, Herndon CD, et al. Hypospadias and early gestation growth restriction in infants. Pediatrics. 2002;109:473-478.
12. Wu WH, Chuang JH, Ting YC, et al. Developmental anomalies and disabilities associated with hypospadias. J Urol. 2002;168:229-232.
13. Silver RI. What is the etiology of hypospadias? A review of recent research. Del Med J. 2000;72:343-347.
14. Fredell L, Lichtenstein P, Pedersen NL, et al. Hypospadias is related to birth weight in discordant monozygotic twins. J Urol. 1998;160:2197-2199.
15. Weidner IS, Møller H, Jensen TK, et al. Risk factors for cryptorchidism and hypospadias. J Urol. 1999;161:1606-1609.
16. Chambers EL, Malone PSJ. The incidence of hypospadias in two English cities: a case-control comparison of possible causal factors. BJU Int. 1999;84:95-98.
17. Wennerholm UB, Bergh C, Hamberger L, et al. Incidence of congenital malformations in children born after ICSI. Hum Reprod. 2000;15:944-948.
18. Klip H, Verloop J, Gool JD, et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet. 2002;359:1102-1107.
19. Lægemiddelkataloget (2004). Dansk Lægemiddel information. Copenhagen, Denmark.
20. Källén B, Olausson PO. Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int J Risk Saf Med. 2001;14:115-119.
21. Diav-Citrin O, Shechtman S, Aharonovich A, et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study. J Allergy Clin Immunol. 2003;111:1239-1243.
22. Moretti ME, Caprara D, Coutinho CJ, et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin Immunol. 2003;111:479-483.
23. Centers for Disease Control and Prevention (CDC). Evaluation of an association between loratadine and hypospadias-United States, 1997-2001. MMWR Morb Mortal Wkly Rep. 2004;53:219-221.
24. Mitchel AA. Special considerations in studies of drug-induced birth defects. In: Strom BL, ed. Pharmacoepidemiology. Chichester: John Wiley & Sons; 1994:595-608.
25. Olsen J, Melbye M, Olsen SF, et al. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health. 2001;29:300-307.
26. Andersen AM, Vastrup P, Wohlfahrt J, et al. Fever in pregnancy and risk of fetal death: a cohort study. Lancet. 2002;360:1552-1556.
27. West SL, Strom BL. Validity of pharmacoepidemiology drug and diagnosis data. In: Strom BL, ed. Pharmacoepidemiology. Chichester: John Wiley & Sons; 1994:549-580.
28. Rockenbauer M, Olsen J, Czeizel AE, et al. EuroMAP Group. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12:461-466.
29. Larsen H, Nielsen GL, Bendsen J, et al. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health. 2003;31:12-16.